The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
Open accessAbstract
A genetic variant in PNPLA3 (PNPLA3(I148M)), a triacylglycerol (TAG) hydrolase, is a major risk factor for nonalcoholic fatty liver disease (NAFLD); however, the mechanism underlying this association is not known. To develop an animal model of PNPLA3-induced fatty liver disease, we generated transgenic mice that overexpress similar amounts of wild-type PNPLA3 (PNPLA3(WT)) or mutant PNPLA3 (PNPLA3(I148M)) either in liver or adipose tissue. Overexpression of the transgenes in adipose tissue did not affect liver fat content. Expression of PNPLA3(I148M), but not PNPLA3(WT), in liver recapitulated the fatty liver phenotype as well as other metabolic features associated with this allele in humans. Metabolic studies provided evidence for 3 distinct alterations in hepatic TAG metabolism in PNPLA3(I148M) transgenic mice: increased formation of fatty acids and TAG, impaired hydrolysis of TAG, and relative depletion of TAG long-chain polyunsaturated fatty acids. These findings suggest that PNPLA3 plays a role in remodeling TAG in lipid droplets, as they accumulate in response to food intake, and that the increase in hepatic TAG levels associated with the I148M substitution results from multiple changes in hepatic TAG metabolism. The development of an animal model that recapitulates the metabolic phenotype of the allele in humans provides a new platform in which to elucidate the role of PNLPA3(I148M) in NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · cited 1×
“At the indicated times, medium was removed, and lipids were extracted using the Folch method (58).”
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Self-citationGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Self-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 2×
“Several factors are associated with an increase in liver TAG content, including obesity, insulin resistance, and alcohol ingestion, but the factors responsible for the wide interindividual differences in hepatic TAG levels have not been fully elucidated (4, 5).”
Self-citationPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
Seale, P., Conroe, H. M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J., Cohen, P., Cinti, S., & Spiegelman, B. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44271 · Cited by 1,252
Ram�rez-Zacar�as, J. L., Castro-Mu�ozledo, F., & Kuri-Harcuch, W. (1992) · Histochemistry · doi:10.1007/bf00316069 · Cited by 1,008
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Sookoian, S., & Pirola, C. J. (2011) · Hepatology · doi:10.1002/hep.24283 · Cited by 920
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 816
Jenkins, C. M., Mancuso, D. J., Yan, W., Sims, H. F., Gibson, B., & Gross, R. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407841200 · Cited by 779
Valenti, L., Al‐Serri, A., Daly, A. K., Galmozzi, E., Rametta, R., Dongiovanni, P., Nobili, V., Mozzi, E., Roviaro, G., Vanni, E., et al. (2010) · Hepatology · doi:10.1002/hep.23622 · Cited by 651
He, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L., Grishin, N. V., Cohen, J. C., & Hobbs, H. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064501 · Cited by 610
Self-citationOu, J., Tu, H., Shan, B., Luk, A., DeBose-Boyd, R. A., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111138698 · Cited by 480
Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E., & Liang, J. T. (2010) · Hepatology · doi:10.1002/hep.23759 · Cited by 475
Cidea-deficient mice have lean phenotype and are resistant to obesity
Zhou, Z., Yon Toh, S., Chen, Z., Guo, K., Peng Ng, C., Ponniah, S., Lin, S.-C., Hong, W., & Li, P. (2003) · Nature Genetics · doi:10.1038/ng1225 · Cited by 467
Variant in PNPLA3 is associated with alcoholic liver disease
Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G., & Hinds, D. A. (2010) · Nature Genetics · doi:10.1038/ng.488 · Cited by 438
A feed-forward loop amplifies nutritional regulation of PNPLA3
Huang, Y., He, S., Li, J. Z., Seo, Y.-K., Osborne, T. F., Cohen, J. C., & Hobbs, H. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003585107 · Cited by 386 · cited 13×
“Regulation is coordinated by the transcription factors liver X receptor (LXR) and SREBP-1c (28).”
InfluentialSelf-citationAdipose Triglyceride Lipase: Function, Regulation by Insulin, and Comparison With Adiponutrin
Kershaw, E. E. (2006) · Diabetes · doi:10.2337/diabetes.55.1.148 · Cited by 386
Sookoian, S., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., Rosselli, M. S., & Pirola, C. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900013-jlr200 · Cited by 370
Speliotes, E. K., Butler, J. L., Palmer, C. D., Voight, B. F., & Hirschhorn, J. N. (2010) · Hepatology · doi:10.1002/hep.23768 · Cited by 362 · cited 1×
“These results parallel the lack of association between the I148M polymorphism and BMI, insulin resistance, or plasma TAG levels observed in humans (7, 11, 16) and suggest that the metabolic mechanisms by which the 148M allele promotes liver fat accumulation may be similar in mice and humans.”
Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites
Gong, J., Sun, Z., Wu, L., Xu, W., Schieber, N., Xu, D., Shui, G., Yang, H., Parton, R. G., & Li, P. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201104142 · Cited by 362
Hepatic Steatosis in Leptin-Deficient Mice Is Promoted by the PPARγ Target Gene Fsp27
Matsusue, K., Kusakabe, T., Noguchi, T., Takiguchi, S., Suzuki, T., Yamano, S., & Gonzalez, F. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.003 · Cited by 347
Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y., & Horton, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35299 · Cited by 333
Hunt, C. R., Ro, J. H., Dobson, D. E., Min, H. Y., & Spiegelman, B. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3786 · Cited by 329
SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells
Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare', O. C., Chen, S., Ren, X., Wu, Z., Streeper, R. S., & Bordone, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.124164 · Cited by 322
Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase
Kumari, M., Schoiswohl, G., Chitraju, C., Paar, M., Cornaciu, I., Rangrez, A. Y., Wongsiriroj, N., Nagy, H. M., Ivanova, P. T., Scott, S. A., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.008 · Cited by 316
Self-citationHuang, Y., Cohen, J. C., & Hobbs, H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290114 · Cited by 314
Self-citationMatsuda, M., Korn, B. S., Hammer, R. E., Moon, Y.-A., Komuro, R., Horton, J. D., Goldstein, J. L., Brown, M. S., & Shimomura, I. (2001) · Genes & Development · doi:10.1101/gad.891301 · Cited by 303
Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members
Lake, A. C., Sun, Y., Li, J.-L., Kim, J. E., Johnson, J. W., Li, D., Revett, T., Shih, H. H., Liu, W., Paulsen, J. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500290-jlr200 · Cited by 295
Self-citationGenetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians
Stickel, F., Buch, S., Lau, K., zu Schwabedissen, H. M., Berg, T., Ridinger, M., Rietschel, M., Schafmayer, C., Braun, F., Hinrichsen, H., et al. (2011) · Hepatology · doi:10.1002/hep.24017 · Cited by 292
Rydel, T. J., Williams, J. M., Krieger, E., Moshiri, F., Stallings, W. C., Brown, S. M., Pershing, J. C., Purcell, J. P., & Alibhai, M. F. (2003) · Biochemistry · doi:10.1021/bi027156r · Cited by 284
Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339
Millar, J. S., Cromley, D. A., McCoy, M. G., Rader, D. J., & Billheimer, J. T. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500019-jlr200 · Cited by 266
Valenti, L., Rumi, M., Galmozzi, E., Aghemo, A., Del Menico, B., De Nicola, S., Dongiovanni, P., Maggioni, M., Fracanzani, A. L., Rametta, R., et al. (2011) · Hepatology · doi:10.1002/hep.24123 · Cited by 264
Baulande, S., Lasnier, F., Lucas, M., & Pairault, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105193200 · Cited by 253
Engelking, L. J., Kuriyama, H., Hammer, R. E., Horton, J. D., Brown, M. S., Goldstein, J. L., & Liang, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20978 · Cited by 249
Chen, W., Chang, B., Li, L., & Chan, L. (2010) · Hepatology · doi:10.1002/hep.23812 · Cited by 247
Basantani, M. K., Sitnick, M. T., Cai, L., Brenner, D. S., Gardner, N. P., Li, J. Z., Schoiswohl, G., Yang, K., Kumari, M., Gross, R. W., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011205 · Cited by 242
Self-citationDeletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice
Moon, Y.-A., Hammer, R. E., & Horton, J. D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800383-jlr200 · Cited by 236
Cortés, V. A., Curtis, D. E., Sukumaran, S., Shao, X., Parameswara, V., Rashid, S., Smith, A. R., Ren, J., Esser, V., Hammer, R. E., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.002 · Cited by 226
Reaven, G. M., Chang, H., & Hoffman, B. B. (1988) · Diabetes · doi:10.2337/diab.37.1.28 · Cited by 217
Simonet, W. S., Bucay, N., Lauer, S. J., & Taylor, J. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53085-4 · Cited by 215
A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo.
Ross, S. R., Graves, R. A., Greenstein, A., Platt, K. A., Shyu, H. L., Mellovitz, B., & Spiegelman, B. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9590 · Cited by 213
Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase
Yen, C.-L. E., Stone, S. J., Cases, S., Zhou, P., & Farese, R. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132274899 · Cited by 210
A MAJOR SOLUBLE GLYCOPROTEIN OF POTATO TUBERS
RACUSEN, D., & FOOTE, M. (1980) · Journal of Food Biochemistry · doi:10.1111/j.1745-4514.1980.tb00876.x · Cited by 190
Li, J. Z., Ye, J., Xue, B., Qi, J., Zhang, J., Zhou, Z., Li, Q., Wen, Z., & Li, P. (2007) · Diabetes · doi:10.2337/db07-0040 · Cited by 189
Self-citationGlyceroneogenesis Is the Dominant Pathway for Triglyceride Glycerol Synthesis in Vivo in the Rat
Nye, C. K., Hanson, R. W., & Kalhan, S. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804393200 · Cited by 182
Doege, K., Grajecki, D., Zyriax, B.-C., Detinkina, E., zu Eulenburg, C., & Buhling, K. J. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511003400 · Cited by 176
Glycerophospholipid Identification and Quantitation by Electrospray Ionization Mass Spectrometry
Ivanova, P. T., Milne, S. B., Byrne, M. O., Xiang, Y., & Brown, H. A. (2007) · Methods in Enzymology · doi:10.1016/s0076-6879(07)32002-8 · Cited by 174
Self-citationHotta, K., Yoneda, M., Hyogo, H., Ochi, H., Mizusawa, S., Ueno, T., Chayama, K., Nakajima, A., Nakao, K., & Sekine, A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-172 · Cited by 174
Trépo, E., Gustot, T., Degré, D., Lemmers, A., Verset, L., Demetter, P., Ouziel, R., Quertinmont, E., Vercruysse, V., Amininejad, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.028 · Cited by 160
Igal, R. A., WANG, P. H., & Coleman, R. (1997) · Biochemical Journal · doi:10.1042/bj3240529 · Cited by 152
Scherer, M., Schmitz, G., & Liebisch, G. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.113779 · Cited by 152
Danesch, U., Hoeck, W. G., & RINGOLD, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50555-5 · Cited by 124
Falleti, E., Fabris, C., Cmet, S., Cussigh, A., Bitetto, D., Fontanini, E., Fornasiere, E., Bignulin, S., Fumolo, E., Bignulin, E., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02534.x · Cited by 123
Burza, M. A., Pirazzi, C., Maglio, C., Sjöholm, K., Mancina, R. M., Svensson, P., Jacobson, P., Adiels, M., Baroni, M. G., Borén, J., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.05.006 · Cited by 120
Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver
Hall, A. M., Kou, K., Chen, Z., Pietka, T., Kumar, M., Korenblat, K., Lee, K., Ahn, K., Fabbrini, E., Klein, S., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p025536 · Cited by 97
Min, H. Y., & Spiegelman, B. M. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.22.8879 · Cited by 94
Castro‐Perez, J. M., Briand, F., Gagen, K., Wang, S., Chen, Y., McLaren, D. G., Shah, V., Vreeken, R. J., Hankemeier, T., Sulpice, T., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m016410 · Cited by 78
Self-citationMyers, D. S., Ivanova, P. T., Milne, S. B., & Brown, H. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.015 · Cited by 75
Self-citationAccelerated Fatty Acid Oxidation in Muscle Averts Fasting-induced Hepatic Steatosis in SJL/J Mice
Guan, H.-P., Goldstein, J. L., Brown, M. S., & Liang, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034397 · Cited by 67
Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia
Jones, C., Garuti, R., Michaely, P., Li, W.-P., Maeda, N., Cohen, J. C., Herz, J., & Hobbs, H. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29415 · Cited by 52
Self-citationPolson, D. A., & Thompson, M. P. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03027-9 · Cited by 48
Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice.
Allan, C. M., & Taylor, J. M. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39135-5 · Cited by 47
Olsson, M. M., Ahlin, S., Olsson, B., Svensson, P., Ståhlman, M., Borén, J., Carlsson, L. M. S., & Sjöholm, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019609 · Cited by 15
Oliver, P., Caimari, A., Díaz‐Rúa, R., & Palou, A. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100434x · Cited by 5
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“Othermetabolic causes of NAFLD andNASH, which are most often genetically related, include (1) defects in intrahepatic lipolysis (e.g., decreased ATGL/CGI-58 activity); (2) defects in triglyceride export (e.g., defective Apo-B 100, MTTP activity); (3) increased glucokinase activity, resulting in increased hepatic DNL;…”
BackgroundInfluentialProgression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Self-citationMechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Kawano, Y., & Cohen, D. E. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0758-5 · Cited by 969
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Metadata
- Authors
- Li, J. Z., Huang, Y., Karaman, R., Ivanova, P. T., Brown, H. A., Roddy, T., Castro-Perez, J., Cohen, J. C., & Hobbs, H. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 11
- Pages
- 4130-4144
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2154914594
- Cited by
- 283
- References
- 71
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.